npf-etoposide has been researched along with helenalin in 1 studies
Studies (npf-etoposide) | Trials (npf-etoposide) | Recent Studies (post-2010) (npf-etoposide) | Studies (helenalin) | Trials (helenalin) | Recent Studies (post-2010) (helenalin) |
---|---|---|---|---|---|
13 | 0 | 0 | 149 | 1 | 43 |
Protein | Taxonomy | npf-etoposide (IC50) | helenalin (IC50) |
---|---|---|---|
photoreceptor-specific nuclear receptor | Homo sapiens (human) | 1.921 | |
XBP1 | Homo sapiens (human) | 2.43 | |
type-1 angiotensin II receptor | Homo sapiens (human) | 18.639 | |
G-protein coupled receptor 55 | Homo sapiens (human) | 2.6423 | |
DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 2.61 | |
transactivating tegument protein VP16 [Human herpesvirus 1] | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | 4.374 | |
Transcriptional activator Myb | Gallus gallus (chicken) | 2.3707 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, KH | 1 |
1 review(s) available for npf-etoposide and helenalin
Article | Year |
---|---|
Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.
Topics: Anti-HIV Agents; Biological Factors; Drug Design; Molecular Structure; Pharmaceutical Preparations; Plants, Medicinal | 2010 |